Epidemiological and Clinical Characteristics of Hospitalized Pediatric Patients with SARS-CoV-2 Infection in Mexico City, Mexico

Table 3

Comparison of symptoms of positive patients with the percentages obtained in the meta-analysis of Cui (2019).

Symptom	SARS-CoV-2 positive, n = 36	Meta-analysis valuesN = 5829	Value
Dyspnoea	8 (22.2%)	NA	NA
Headache	11 (30.6%)	NA	NA
Fever	33 (91.7%)	51%	<0.001
Cough	17 (47.2%)	41%	0.4
Sore throat	9 (25.0%)	16%	<0.001
Tachycardia	4 (11.1%)	12%	1
Rhinorrhea	11 (30.6%)	14%	0.01
Nasal congestion	2 (5.6%)	17%	0.07
Tachypnea	7 (19.4%)	9%	0.03
Diarrhea	7 (19.4%)	8%	0.02
Vomiting	13 (15.3%)	7%	<0.001
Myalgia	7 (19.4%)	12%	0.1
Fatigue	8 (22.2%)	12%	0.07
Hypoemia	3 (8.3%)	3%	0.09
Chest pain	3 (8.3%)	3%	0.09

Taken from J Med Virol. 2021; 93: 1057–1069 (15). Significant values are bolded; NA, no applicable.